Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From genes to decisions: evolving views of genotype-based management in MEN 2.

Cancer treatment and research - 1 Jan 2004

Mulligan Lois M

Abstract excerpt

Diagnosis and management of MEN 2 has evolved considerably since the identification of the underlying disease mutations in the RETproto-oncogene. Presymptomatic detection and prophylactic surgical intervention are now the accepted standard of care. The strong correlation of disease phenotype and mutation genotype has already also allowed us to develop mutation-guided management strategies to optimize time ot...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Making
Share to Genotype
Share to Multiple Endocrine Neoplasia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-ret

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 16209059

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From genes to decisions: evolving views of genotype-based management in MEN 2.PMID 16209059Read ↗

Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene.Semantic proximity Read ↗

MEN syndromes.Semantic proximity Read ↗

5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision MedicineSemantic proximity Read ↗

The MEN II syndromes and the role of the ret proto-oncogene.Semantic proximity Read ↗

Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.Semantic proximity Read ↗

RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.Semantic proximity Read ↗

Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.Semantic proximity Read ↗

[Diagnosis and management of asymptomatic MEN 2 gene carriers].Semantic proximity Read ↗

Defining and refining the phenotype of PRRT2 mutations.Semantic proximity Read ↗

The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2Semantic proximity Read ↗

Genotype-specific development of MEN 2 constituent components in 683 RET carriers.Semantic proximity Read ↗

MEN2 screening dilemmas in a family with a novel RET mutation in the MEN2 susceptibility region of the gene, a family history of Hirschsprung disease, and no family history of MEN2-related tumours.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.